MacroGenics Inc (MGNX)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
Coya Therapeutics Inc (COYA)
HUTCHMED DRC (HCM)
[Press Release] HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for wAIHA in China